Sana Biotechnology Inc vs Tripadvisor Inc Common Stock — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Tripadvisor Inc Common Stock is the larger of the two by market cap, and Tripadvisor Inc Common Stock is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| SANA | TRIP | |
|---|---|---|
Market Cap | $873.84M | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $19.14 |
52-Week Low | $2.68 | $9.24 |
Enterprise Value | $848.03M | $1.80B |
Trailing returns across standard periods
Latest headlines on both assets
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →